Thomas Gayner - Markel Group Inc. 13F Activity & Position Changes (Q1 2021)

According to the SEC 13F filed on Apr 30, 2021, the Markel Group Inc. portfolio showed several notable changes in holdings as of quarter-end Mar 31, 2021. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q1 2021, the filing reported:

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Showing 30 of 38 transactions.

Date Symbol Type Change Qty
Q1 2021
ADM
Archer-Daniels-Midland Company
Sell
-15,000
Q1 2021
AMT
American Tower Corporation (REI
Buy
+580
Q1 2021
AON
Aon Plc
Buy
+4,500
Q1 2021
AXP
American Express Company
Buy
+200
Q1 2021
BAM
Brookfield Asset Management Inc
Buy
+2,380
Q1 2021
BK
The Bank of New York Mellon Cor
Buy
+1,000
Q1 2021
CE
Celanese Corporation
Buy - Position Entry
+2,400
Q1 2021
CMCSA
Comcast Corporation
Buy
+3,740
Q1 2021
DEO
Diageo plc
Buy
+100
Q1 2021
DIS
Walt Disney Company (The)
Buy
+360
Q1 2021
EFX
Equifax, Inc.
Buy
+8,100
Q1 2021
EMN
Eastman Chemical Company
Buy
+3,000
Q1 2021
GS
Goldman Sachs Group, Inc. (The)
Buy
+160
Q1 2021
GWRE
Guidewire Software, Inc.
Sell - Position Exit
-13,000
Q1 2021
ICE
Intercontinental Exchange Inc.
Buy - Position Entry
+2,320
Q1 2021
IFF
International Flavors & Fragran
Buy
+10,000
Q1 2021
KKR
KKR & Co. Inc.
Buy
+13,000
Q1 2021
LMT
Lockheed Martin Corporation
Buy - Position Entry
+1,293
Q1 2021
LOW
Lowe's Companies, Inc.
Buy
+180
Q1 2021
MA
Mastercard Incorporated
Buy
+40
Q1 2021
MCHP
Microchip Technology Incorporat
Sell
-107,000
Q1 2021
MCO
Moody's Corporation
Buy
+140
Q1 2021
META
Meta Platforms, Inc.
Buy
+1,323
Q1 2021
MMM
3M Company
Buy
+3,900
Q1 2021
MSFT
Microsoft Corporation
Buy
+580
Q1 2021
NVR
NVR, Inc.
Buy
+10
Q1 2021
OI
O-I Glass, Inc.
Sell
-354,000
Q1 2021
OTIS
Otis Worldwide Corporation
Buy
+800
Q1 2021
PGR
Progressive Corporation (The)
Buy
+15,600
Q1 2021
REGN
Regeneron Pharmaceuticals, Inc.
Buy - Position Entry
+45,500